ITRM20040178A1 - Composti ad attivita' antipsicotica atipica. - Google Patents

Composti ad attivita' antipsicotica atipica.

Info

Publication number
ITRM20040178A1
ITRM20040178A1 IT000178A ITRM20040178A ITRM20040178A1 IT RM20040178 A1 ITRM20040178 A1 IT RM20040178A1 IT 000178 A IT000178 A IT 000178A IT RM20040178 A ITRM20040178 A IT RM20040178A IT RM20040178 A1 ITRM20040178 A1 IT RM20040178A1
Authority
IT
Italy
Prior art keywords
compounds
atypical antipsychotic
antipsychotic activity
activity
atypical
Prior art date
Application number
IT000178A
Other languages
English (en)
Inventor
Stefania Butini
Giuseppe Campiani
Cesare Maria Assunta Di
Patrizia Minetti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000178A priority Critical patent/ITRM20040178A1/it
Publication of ITRM20040178A1 publication Critical patent/ITRM20040178A1/it
Priority to TW094108067A priority patent/TW200539865A/zh
Priority to ARP050101325A priority patent/AR048464A1/es
Priority to EP05734787A priority patent/EP1737866A2/en
Priority to JP2007506913A priority patent/JP2007532528A/ja
Priority to AU2005232160A priority patent/AU2005232160A1/en
Priority to CNA2005800078560A priority patent/CN1980931A/zh
Priority to CA002555859A priority patent/CA2555859A1/en
Priority to BRPI0509648-0A priority patent/BRPI0509648A/pt
Priority to MXPA06011293A priority patent/MXPA06011293A/es
Priority to KR1020067019434A priority patent/KR20070004747A/ko
Priority to US11/578,113 priority patent/US20080293689A1/en
Priority to PCT/IT2005/000182 priority patent/WO2005097797A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
IT000178A 2004-04-07 2004-04-07 Composti ad attivita' antipsicotica atipica. ITRM20040178A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT000178A ITRM20040178A1 (it) 2004-04-07 2004-04-07 Composti ad attivita' antipsicotica atipica.
TW094108067A TW200539865A (en) 2004-04-07 2005-03-16 Compounds with atypical antipsychotic activity
ARP050101325A AR048464A1 (es) 2004-04-07 2005-04-04 Compuestos con actividad antipsicotica atipica
PCT/IT2005/000182 WO2005097797A2 (en) 2004-04-07 2005-04-05 Compounds with atypical antipsychotic activity
JP2007506913A JP2007532528A (ja) 2004-04-07 2005-04-05 非定型抗精神病活性を有する化合物
EP05734787A EP1737866A2 (en) 2004-04-07 2005-04-05 Compounds with atypical antipsychotic activity
AU2005232160A AU2005232160A1 (en) 2004-04-07 2005-04-05 Compounds with atypical antipsychotic activity
CNA2005800078560A CN1980931A (zh) 2004-04-07 2005-04-05 具有非典型抗精神病活性的化合物
CA002555859A CA2555859A1 (en) 2004-04-07 2005-04-05 Compounds with atypical antipsychotic activity
BRPI0509648-0A BRPI0509648A (pt) 2004-04-07 2005-04-05 compostos com atividade antipsicótica atìpica
MXPA06011293A MXPA06011293A (es) 2004-04-07 2005-04-05 Compuestos con actividad antipsicotica atipica.
KR1020067019434A KR20070004747A (ko) 2004-04-07 2005-04-05 특이적 항정신병 활성을 가지는 화합물
US11/578,113 US20080293689A1 (en) 2004-04-07 2005-04-05 Compounds with Atypical Antipsychotic Activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000178A ITRM20040178A1 (it) 2004-04-07 2004-04-07 Composti ad attivita' antipsicotica atipica.

Publications (1)

Publication Number Publication Date
ITRM20040178A1 true ITRM20040178A1 (it) 2004-07-07

Family

ID=34965603

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000178A ITRM20040178A1 (it) 2004-04-07 2004-04-07 Composti ad attivita' antipsicotica atipica.

Country Status (13)

Country Link
US (1) US20080293689A1 (it)
EP (1) EP1737866A2 (it)
JP (1) JP2007532528A (it)
KR (1) KR20070004747A (it)
CN (1) CN1980931A (it)
AR (1) AR048464A1 (it)
AU (1) AU2005232160A1 (it)
BR (1) BRPI0509648A (it)
CA (1) CA2555859A1 (it)
IT (1) ITRM20040178A1 (it)
MX (1) MXPA06011293A (it)
TW (1) TW200539865A (it)
WO (1) WO2005097797A2 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6457527B2 (ja) * 2013-12-11 2019-01-23 バイエル・クロップサイエンス・アクチェンゲゼルシャフト ハロゲン化ジ置換ベンジルアミン類、特にハロゲン化ジアルキルベンジルアミン類の製造方法
CN112704678B (zh) * 2020-12-02 2024-02-23 江苏恩华药业股份有限公司 一种丙酰胺衍生物在制备治疗精神分裂症药物中应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
IT1301965B1 (it) * 1998-07-28 2000-07-20 Sigma Tau Ind Farmaceuti Pirrolo (2,1-b)(1,3) benzotiazepine con attivita' antipsicoticaatipica.
IT1317884B1 (it) * 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Pirrolo (2,1-b)(1,3)benzotiazepine e loro uso per la preparazione dimedicamenti ad attivita' antipsicotica classica.

Also Published As

Publication number Publication date
BRPI0509648A (pt) 2007-09-18
MXPA06011293A (es) 2007-01-16
CN1980931A (zh) 2007-06-13
US20080293689A1 (en) 2008-11-27
CA2555859A1 (en) 2005-10-20
KR20070004747A (ko) 2007-01-09
WO2005097797A3 (en) 2005-11-10
AR048464A1 (es) 2006-04-26
EP1737866A2 (en) 2007-01-03
AU2005232160A1 (en) 2005-10-20
WO2005097797A2 (en) 2005-10-20
JP2007532528A (ja) 2007-11-15
TW200539865A (en) 2005-12-16

Similar Documents

Publication Publication Date Title
NL1028967A1 (nl) 4-Fenylamino-chinazoline-6-yl-amiden.
ATE506362T1 (de) 1-aza-bicycloä3.3.1ünonane
NO20053210D0 (no) Linneslakkompensator.
NO20041374D0 (no) Bolgekraftverk.
NL1030382A1 (nl) Gesubstitueerde N-sulfonylaminobenzyl-2-fenoxyaceetamide verbindingen.
NO20040762D0 (no) Stromskinne.
NO20052746D0 (no) Avlopsenhet.
ITMI20040124A1 (it) Macrolidi ad attivita' antiinfiammatoria
DE602005004827D1 (de) Lageranordnung
ES1061567Y (es) "conjunto rodadero"
DE602005004472D1 (de) Ausgleichsanordnung
DE602005022201D1 (de) Lageranordnung
NO20052482D0 (no) Redningskokong.
ATA2632004A (de) Ballenauflöser
ITMI20040230A1 (it) Composti ad attivita' antitumorale
ITRM20040178A1 (it) Composti ad attivita' antipsicotica atipica.
DE502005011293D1 (de) Gleitlageranordnung
FR2878980B1 (fr) Unite de retro-eclairage de type direct.
NL1028622A1 (nl) Stelwig.
NL1025196A1 (nl) Hark-Zeef-Vork.
ITMI20050534A1 (it) Composti ad attivita'antitumorale
ITBO20050476A1 (it) Composti organici ad attivita' antitumorale
ITMO20040291A1 (it) Telefono viva-voce ad utilizzo per utenza ampliata.
ES1057650Y (es) Camison hospitalario.
ITFR20040018A1 (it) Antislavina & i.s.m.